Abilify and Tuberculosis - a phase IV clinical study of FDA data

Summary:

Tuberculosis is reported as a side effect among people who take Abilify (aripiprazole), especially for people who are male, 50-59 old, also take Xanax, and have Schizoaffective disorder.

The phase IV clinical study analyzes which people have Tuberculosis when taking Abilify. It is created by eHealthMe based on reports of 97,308 people who have side effects when taking Abilify from the FDA, and is updated regularly.

What is Abilify?

Abilify has active ingredients of aripiprazole. It is often used in depression. eHealthMe is studying from 101,453 Abilify users. Check the latest studies of Abilify.

What is Tuberculosis?

Tuberculosis (a bacterial infection by mycobacterium tuberculosis) is found to be associated with 635 drugs and 766 conditions by eHealthMe. Check the latest studies of Tuberculosis.

On Jun, 14, 2026

97,308 people reported to have side effects when taking Abilify.
Among them, 12 people (0.01%) have Tuberculosis.

Among these 12 people:

What is the gender of people who have Tuberculosis when taking Abilify? *

female: 45.45 %
male: 54.55 %

What is the age of people who have Tuberculosis when taking Abilify? *

What are other drugs people take besides Abilify? *

Xanax: 3 people, 25.00%
Zyprexa: 1 person, 8.33%
Melatonin: 1 person, 8.33%
Bacitracin Zinc And Polymyxin B Sulfate: 1 person, 8.33%
Benzonatate: 1 person, 8.33%
Buspirone Hcl: 1 person, 8.33%
Celexa: 1 person, 8.33%
Effexor: 1 person, 8.33%
Effexor Xr: 1 person, 8.33%
Geodon: 1 person, 8.33%

What are other side effects people have besides Tuberculosis? *

Hyperglycemia (high blood sugar): 2 people, 16.67%
Weight Loss: 1 person, 8.33%
Weight Decreased: 1 person, 8.33%
Injury: 1 person, 8.33%
Infertility: 1 person, 8.33%
Impulsive Behavior: 1 person, 8.33%
Hyperhidrosis (abnormally increased sweating): 1 person, 8.33%
Herpes Simplex (herpes simplex is a common viral infection): 1 person, 8.33%
Heart Attack: 1 person, 8.33%
Headache (pain in head): 1 person, 8.33%

What are the existing conditions these people have? *

Schizoaffective Disorder (a mental disorder characterized by disordered thought): 2 people, 16.67%
Viral Infection: 1 person, 8.33%
Hepatitis C: 1 person, 8.33%
Affective Disorder (mental disorder): 1 person, 8.33%
Birth Control: 1 person, 8.33%
Cough: 1 person, 8.33%
Dysmenorrhea (painful menstruation): 1 person, 8.33%
Fever: 1 person, 8.33%
Gastric Ulcer (stomach ulcer): 1 person, 8.33%
Hypersensitivity: 1 person, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Abilify and have Tuberculosis?

- Check whether Tuberculosis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Abilify:

Abilify (101,453 reports)

Tuberculosis treatments and more:

Tuberculosis (26,436 reports)

Browse all side effects of Abilify:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Tuberculosis:

Tuberculosis (635 drugs)

Browse all the conditions that are associated with Tuberculosis:

Tuberculosis (766 conditions)

Related publications that referenced our studies

Cetin, M., Celik, M., Cakici, M., Polat, M., & Suner, A, "Aripiprazole-Induced Hoarseness", Turk Psikiyatri Dergisi, 2018 Jan .
Cetin M, Celik M, Cakici M, Polat M, Suner A, "Aripiprazole induced non-cardiogenic pulmonary edema: a case report", Turk Psikiyatri Dergisi, 2014 Dec .
Cetin, M., Celik, M., Cakici, M., Polat, M., & Suner, A, "Aripiprazole-Induced Hoarseness", Turk Psikiyatri Dergisi, 2018 Jan .
Cetin M, Celik M, Cakici M, Polat M, Suner A, "Aripiprazole induced non-cardiogenic pulmonary edema: a case report", Turk Psikiyatri Dergisi, 2014 Dec .

How the study uses the data?

The study uses data from the FDA. It is based on aripiprazole (the active ingredients of Abilify) and Abilify (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.